PHOENIX BIOTECH ACQUISITION CORP.
PHOENIX BIOTECH ACQUISITION CORP. (PBAX) is a publicly traded company in the Unknown sector. Across all available filings, 3 corporate insiders have executed 3 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Oct 8, 2021 involved a transaction of 10,000 shares valued at $0.
PBAX Insider Activity Summary
Who Is Buying PBAX Stock?
No significant insider buying has been recorded for PBAX in the recent period.
Who Is Selling PBAX Stock?
No significant insider selling has been recorded for PBAX in the recent period.
Is PHOENIX BIOTECH ACQUISITION CORP. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for PBAX is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
PBAX Frequently Asked Questions
Understanding PBAX Insider Activity
Insider trading at PHOENIX BIOTECH ACQUISITION CORP. (PBAX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 3 insiders are actively trading PBAX stock, having executed 3 transactions in the past 90 days. The most active insider is Christopher B. Ehrlich (Executive), who has made 1 transactions totaling $367.3K.
Related Tools
Track PHOENIX BIOTECH ACQUISITION CORP. Insider Activity
Get notified when executives and directors at PBAX file new Form 4 transactions